Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes.
about
Epileptogenesis in neurocutaneous disorders with focus in Sturge Weber syndromeCurrent Therapeutic Options in Sturge-Weber Syndrome[Sturge-Weber syndrome].New vascular classification of port-wine stains: improving prediction of Sturge-Weber risk.Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research.Brain Vascular Malformation Consortium: Overview, Progress and Future DirectionsPreliminary reliability and validity of a battery for assessing functional skills in children with Sturge-Weber syndrome.Stimulant use in patients with sturge-weber syndrome: safety and efficacy.[Formula: see text]Intellectual and adaptive functioning in Sturge-Weber Syndrome.Focal venous hypertension as a pathophysiologic mechanism for tissue hypertrophy, port-wine stains, the Sturge-Weber syndrome, and related disorders: proof of concept with novel hypothesis for underlying etiological cause (an American OphthalmologicEpilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber Syndrome.Neurocutaneous Disorders for the Practicing Neurologist: a Focused Review.Visual outcome in Sturge-Weber syndrome: a systematic review and Dutch multicentre cohort.Correction of Facial Deformity in Sturge-Weber Syndrome.Aspirin therapy in venous malformation: a retrospective cohort study of benefits, side effects, and patient experiences.Screening for Sturge-Weber syndrome: A state-of-the-art review.Sturge-weber syndrome.
P2860
Q26750613-C25E6170-465C-4AC3-A8B3-ABD7E1304462Q26771926-9D48EA18-7C48-4B8B-A65A-58C50A0262C0Q30704892-AE9A9923-D532-4915-AA1C-AA09520999BCQ30833931-9ADE59C2-615B-422C-B192-0AEB450CCB30Q33902151-E7F3BE03-5C91-42FD-BA71-6E7409A4C9FBQ34160000-5B5D3DE9-A493-4150-B5AF-4DEDE4817E33Q34769649-73D2D1A8-3E82-479C-9489-F8F5AC8DDE23Q35357653-5B89B6AB-8BB0-4717-A4F9-53F241FA9F94Q36904253-2F19CF97-47E9-4DEA-856D-CABB0CEB7F51Q37411764-918805EB-1A95-4201-88FD-DB72923C0017Q37707250-315489FA-3CFC-42AF-A063-FF59E5DB1B44Q38694212-5B4C5172-FCED-4E6B-82BB-2046290D215CQ38847870-752C6D38-65A5-487C-9976-8E84B5B1215BQ38953037-5B4897D0-7998-409E-A527-D220B758D363Q46116176-1BEDEA65-35DD-411A-BE7E-60791DED714AQ48017347-DB2ECFFE-9072-47B9-8019-982E66E644F0Q51383130-A61D093B-6873-45C9-AA00-766FDFE1FB51
P2860
Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes.
@ast
Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes.
@en
type
label
Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes.
@ast
Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes.
@en
prefLabel
Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes.
@ast
Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes.
@en
P2093
P2860
P356
P1476
Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes.
@en
P2093
Aditya K Sreenivasan
Anne M Comi
Eboni I Lance
Eric H Kossoff
T Andrew Zabel
P2860
P304
P356
10.1177/0883073812463607
P577
2012-10-30T00:00:00Z